AstraZeneca has suggested it would have welcomed a bid of £58-a-share after rejecting the offer of £55-a-share by US drug firm Pfizer, ITV News Business Editor Joel Hills reports:
AstraZeneca rebuffs "final" offer of £55/share but seems to suggest that it would have recommended a bid of £58+ to shareholders.
Pfizer has said its bid is "final" and won't go hostile, its only hope now is if AstraZeneca's shareholders rebel against the board.
AstraZeneca's shares closed Friday at £48, before "first contact" were £35. Market opens at 08.00
Pfizer has until Monday until it admits defeat in bidding for AstraZeneca. But after the shenanigans of the past few days we cannot be sure.
AstraZeneca's share price is tumbling back down to earth after the board rejected a "final" Pfizer bid. So is the takeover really over?
Sweden's Finance Minister says the Government should be "very, very sceptical" about any promises the US pharmaceutical giant makes.